| 2011 |
OATL1 (TBC1D25) directly binds Atg8 homologues (LC3 family) via a direct protein-protein interaction, enabling its recruitment to isolation membranes and autophagosomes. Its TBC/RabGAP activity targets Rab33B (an Atg16L1-binding Rab GTPase), and both the GAP activity and the Atg8-binding activity are required for OATL1 to promote autophagosome–lysosome fusion (autophagosomal maturation). |
Co-immunoprecipitation, direct binding assays, GAP activity assays, dominant-negative and loss-of-function (siRNA knockdown) with autophagosome–lysosome fusion readout, and subcellular localization by fluorescence microscopy |
The Journal of cell biology |
High |
21383079
|
| 2016 |
TBC1D25 escapes autophagic degradation despite being an LC3-binding protein because it lacks oligomerization ability, causing it to localize asymmetrically to the outer autophagosome membrane. Forced oligomerization of TBC1D25 redirects it to both inner and outer membranes and converts it into an autophagic substrate, demonstrating that oligomerization state governs whether an LC3-binding protein is degraded by autophagy. |
Chimeric protein analysis between TBC1D25 and SQSTM1/p62, forced oligomerization constructs, ultrastructural (electron microscopy) localization, autophagic degradation assays |
Autophagy |
High |
26902585
|
| 2020 |
TBC1D25 directly interacts with TAK1 (MAP3K7) through residues 138–226 in the C-terminal region of TBC1D25 and residues 1–300 in the C-terminal region of TAK1. TBC1D25 suppresses TAK1 auto-phosphorylation and downstream JNK/p38 activation; knockout of TBC1D25 increases TAK1, JNK, and p38 phosphorylation, exacerbating pathological cardiac hypertrophy and fibrosis. |
Co-immunoprecipitation and GST pull-down assays (domain mapping), TBC1D25-KO mouse model with TAC-induced cardiac remodeling, TBC1D25 overexpression in H9C2 cells and NRCMs with Angiotensin II treatment, western blot for phospho-TAK1/JNK/p38 |
International journal of biological sciences |
Medium |
32210723
|
| 2016 |
RNAi-based high-content screening identified OATL1 (TBC1D25) as required for normal intracellular trafficking of polystyrene nanoparticles in HeLa cells, placing it alongside Rab33b and Myosin VI in the endocytic/trafficking pathway. |
siRNA knockdown, high-content fluorescence microscopy screening of 408 genes, quantitative trafficking assay with fluorescent nanoparticles |
Scientific reports |
Low |
27374232
|
| 2020 |
TBC1D25 localizes to the sealing zone (co-localizing with F-actin) and ruffled membrane in human osteoclasts, and siRNA-mediated inhibition of TBC1D25 significantly reduces bone resorption, formation of multinucleated cells, and nuclei per cell, indicating a role in osteoclast polarization and multinucleation. |
Immunofluorescence colocalization in human osteoclast cultures, siRNA knockdown with bone resorption pit assay and multinucleation quantification |
European journal of cell biology |
Medium |
33353759
|
| 2021 |
A missense variant in TBC1D25 [p.(Glu50Ala)] segregating with X-linked oligozoospermia in a human family is predicted to disrupt interaction with ATG8 homologues, implicating TBC1D25's Atg8-binding function in spermatogenesis; however, the functional consequence of this specific variant was not directly tested in cell or animal models in this study. |
Exome sequencing, variant segregation analysis; functional consequence inferred from known Atg8-binding site but not experimentally validated in this paper |
European journal of medical genetics |
Low |
33460826
|